ByteBrief
We're a portrait publication through and through. Turn your phone back and your briefing picks up right where you left it.
(We tried widescreen once. It wasn't us.)

Chai Discovery raised $400 million in Series C funding at a $3.8 billion valuation, led by Index Ventures with participation from Kleiner Perkins, Sequoia Capital, and Dimension. The company develops AI models for molecular design and drug discovery, and its latest model Chai-3 doubles success rates for molecular interaction targets.
Tap to vote and see what everyone thinks.
Summary by ByteBrief